The role of the glutamine transporter ASCT2 in antineoplastic therapy Estefânia TeixeiraCláudia SilvaFátima Martel Review Article 19 January 2021 Pages: 447 - 464
Dose adjustment of venetoclax when co-administered with posaconazole: clinical drug–drug interaction predictions using a PBPK approach Sumit BhatnagarDwaipayan MukherjeeJohn P. Gibbs Original Article 04 January 2021 Pages: 465 - 474
Effect of ceritinib on the pharmacokinetics of coadministered CYP3A and 2C9 substrates: a phase I, multicenter, drug–drug interaction study in patients with ALK + advanced tumors Felipe K. HurtadoFilippo de BraudMorten Mau-Sorensen Original Article Open access 04 January 2021 Pages: 475 - 486
Demethoxycucumin protects MDA-MB-231 cells induced bone destruction through JNK and ERK pathways inhibition Xiaofeng ShenXiaochen SunYuwei Li Original Article 05 January 2021 Pages: 487 - 499
Population pharmacokinetic model development and exposure–response analysis of vincristine in patients with malignant lymphoma Toshiaki IgarashiShinji KishiTakanori Ueda Original Article 08 January 2021 Pages: 501 - 511
Concentration–QTc analysis of quizartinib in patients with relapsed/refractory acute myeloid leukemia Dongwoo KangElizabeth LudwigOphelia Yin Original Article Open access 08 January 2021 Pages: 513 - 523
A phase I study of intravenous fenretinide (4-HPR) for patients with malignant solid tumors Jacob S. ThomasAnthony B. El-KhoueiryEdward M. Newman Original Article 10 January 2021 Pages: 525 - 532
Does bevacizumab increase joint pain in patients with cancer? Results of the prospective observational BEVARTHRALGIA study Enora VauléonHélène BehalAnthony Turpin Original Article 12 January 2021 Pages: 533 - 541
Phase II clinical trial of nab-paclitaxel plus gemcitabine in elderly patients with previously untreated locally advanced or metastatic pancreatic adenocarcinoma: the BIBABRAX study Jaime FeliuMónica Jorge FernándezGuillermo López-Vivanco Original Article 15 January 2021 Pages: 543 - 553
Correlations between serum cetuximab and EGFR-related markers, and skin disorders in head and neck cancer patients Kaito ShibataTakafumi NaitoJunichi Kawakami Original Article 19 January 2021 Pages: 555 - 565
5-Fluorouracil disrupts ovarian preantral follicles in young C57BL6J mice Juliana Z. AlmeidaLaritza F. LimaReinaldo B. Oriá Original Article 20 January 2021 Pages: 567 - 578
Severe toxicity of capecitabine in a patient with DPD deficiency after a safe FEC-100 experience: why we should test DPD deficiency in all patients before high-dose fluoropyrimidines Maud MaillardAudrey Eche-GassFabienne Thomas Short Communication 15 February 2021 Pages: 579 - 583
Correction to: A placebo‑controlled, double‑blind, randomized study of recombinant thrombomodulin (ART‑123) to prevent oxaliplatin‑induced peripheral neuropathy Masahito KotakaYoji SaitoIchinosuke Hyodo Correction 02 November 2020 Pages: 585 - 586